Moderna Reiterates 10% Revenue-Growth Target as Covid Vaccine Demand Falls

Date:




Moderna reported falling fourth-quarter sales as Covid-19 vaccine demand continued to drop, but continues to target 10% revenue growth in 2026 following the launch of its next-generation Covid vaccine.



Source link

Share post:

Subscribe

spot_imgspot_img

Popular

More like this
Related